Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Siang Fei Yeoh, Tae Jin Lee, Ka Lip Chew, Stephen Lin, Dennis Yeo & Sajita Setia. (2018) Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. Infection and Drug Resistance 11, pages 805-819.
Read now
Read now
Mario Cruciani & Giovanni Serpelloni. (2008) Management of Candida infections in the adult intensive care unit. Expert Opinion on Pharmacotherapy 9:2, pages 175-191.
Read now
Read now
Laura Waters & Mark Nelson. (2007) The use of caspofungin in HIV-infected individuals. Expert Opinion on Investigational Drugs 16:6, pages 899-908.
Read now
Read now
Michael A Pfaller. (2004) Anidulafungin: an echinocandin antifungal. Expert Opinion on Investigational Drugs 13:9, pages 1183-1197.
Read now
Read now
Articles from other publishers (53)
Olabayo H. Ajetunmobi, Hamid Badali, Jesus A. Romo, Gordon Ramage & Jose L. Lopez-Ribot. (2023) Antifungal therapy of Candida biofilms: Past, present and future. Biofilm 5, pages 100126.
Crossref
Crossref
Maria Antonia De Francesco. (2023) Drug-Resistant Aspergillus spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe. Pathogens 12:11, pages 1305.
Crossref
Crossref
Thaila Fernanda dos Reis, Patrícia Alves de Castro, Rafael Wesley Bastos, Camila Figueiredo Pinzan, Pedro F. N. Souza, Suzanne Ackloo, Mohammad Anwar Hossain, David Harold Drewry, Sondus Alkhazraji, Ashraf S. Ibrahim, Hyunil Jo, Jorge D. Lightfoot, Emily M. Adams, Kevin K. Fuller, William F. deGrado & Gustavo H. Goldman. (2023) A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi. Nature Communications 14:1.
Crossref
Crossref
V. Sabareesh & V. S. Gowri. 2023. Fungi and Fungal Products in Human Welfare and Biotechnology. Fungi and Fungal Products in Human Welfare and Biotechnology
159
185
.
Hajar Yaakoub, Jean-Paul Latgé & Nicolas Papon. (2022) Central Sugar Metabolism and the Cell Wall. mBio 13:5.
Crossref
Crossref
A. Arastehfar, A. Carvalho, J. Houbraken, L. Lombardi, R. Garcia-Rubio, J.D. Jenks, O. Rivero-Menendez, R. Aljohani, I.D. Jacobsen, J. Berman, N. Osherov, M.T. Hedayati, M. Ilkit, D. Armstrong-James, T. Gabaldón, J. Meletiadis, M. Kostrzewa, W. Pan, C. Lass-Flörl, D.S. Perlin & M. Hoenigl. (2021)
Aspergillus fumigatus
and aspergillosis: From basics to clinics
. Studies in Mycology 100:1, pages 100115-100115.
Crossref
Crossref
Murat C. Kalem, Harini Subbiah, Jay Leipheimer, Virginia E. Glazier & John C. Panepinto. (2021) Puf4 Mediates Post-transcriptional Regulation of Cell Wall Biosynthesis and Caspofungin Resistance in Cryptococcus neoformans. mBio 12:1.
Crossref
Crossref
Liza C. Loza & Tamara L. Doering. 2021. Comprehensive Glycoscience. Comprehensive Glycoscience
479
506
.
Ling Ye, Jiaxing Zhang, Wei Xiao & Shuwen Liu. (2020) Efficacy and mechanism of actions of natural antimicrobial drugs. Pharmacology & Therapeutics 216, pages 107671.
Crossref
Crossref
Gina Wall & Jose L. Lopez-Ribot. (2020) Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy. Antibiotics 9:8, pages 445.
Crossref
Crossref
Soraia L. Lima, Arnaldo L. Colombo & João N. de Almeida Junior. (2019) Fungal Cell Wall: Emerging Antifungals and Drug Resistance. Frontiers in Microbiology 10.
Crossref
Crossref
Tscherner & Kuchler. (2019) A Histone Acetyltransferase Inhibitor with Antifungal Activity against CTG clade Candida Species. Microorganisms 7:7, pages 201.
Crossref
Crossref
Shruthi Satish, Cristina Jiménez-Ortigosa, Yanan Zhao, Min Hee Lee, Enriko Dolgov, Thomas Krüger, Steven Park, David W. Denning, Olaf Kniemeyer, Axel A. Brakhage & David S. Perlin. (2019)
Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-
d
-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus
. mBio 10:3.
Crossref
Crossref
Harshad Devarbhavi, Herbert L. Bonkovsky, Mark Russo & Naga Chalasani. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
844
890.e17
.
Heidrun Anke & Hartmut Laatsch. 2018. Physiology and Genetics. Physiology and Genetics
331
365
.
Romuald Bellmann & Piotr Smuszkiewicz. (2017) Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection 45:6, pages 737-779.
Crossref
Crossref
Kristie D. Goughenour, Joan-Miquel Balada-Llasat & Chad A. Rappleye. (2015) Quantitative Microplate-Based Growth Assay for Determination of Antifungal Susceptibility of Histoplasma capsulatum Yeasts. Journal of Clinical Microbiology 53:10, pages 3286-3295.
Crossref
Crossref
Curtis D. Holt & Drew J. Winston. 2015. Transplantation of the Liver. Transplantation of the Liver
1006
1039
.
Herbert L. Bonkovsky, Dean P. Jones, Mark W. Russo & Steven I. Shedlofsky. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
417
461
.
Rajendra P. Pawar, Babasaheb A. Kushekar, Bhaskar S. Jadhav, Kiran R. Kharat, Ravikumar M. Borade & Abraham J. Domb. 2011. Biodegradable Polymers in Clinical Use and Clinical Development. Biodegradable Polymers in Clinical Use and Clinical Development
217
245
.
Christopher F. Hoehamer, Edwin D. Cummings, George M. Hilliard & P. David Rogers. (2010)
Changes in the Proteome of
Candida albicans
in Response to Azole, Polyene, and Echinocandin Antifungal Agents
. Antimicrobial Agents and Chemotherapy 54:5, pages 1655-1664.
Crossref
Crossref
Elvira Román, Fabien Cottier, Joachim F. Ernst & Jesús Pla. (2009)
Msb2 Signaling Mucin Controls Activation of Cek1 Mitogen-Activated Protein Kinase in
Candida albicans
. Eukaryotic Cell 8:8, pages 1235-1249.
Crossref
Crossref
Guillermo Garcia-Effron, Steven Park & David S. Perlin. (2009)
Correlating Echinocandin MIC and Kinetic Inhibition of
fks1
Mutant Glucan Synthases for
Candida albicans
: Implications for Interpretive Breakpoints
. Antimicrobial Agents and Chemotherapy 53:1, pages 112-122.
Crossref
Crossref
Heidrun Anke & Luis Antelo. 2009. Physiology and Genetics. Physiology and Genetics
273
296
.
John D. Cleary, Guillermo Garcia-Effron, Stanley W. Chapman & David S. Perlin. (2008)
Reduced
Candida glabrata
Susceptibility Secondary to an
FKS1
Mutation Developed during Candidemia Treatment
. Antimicrobial Agents and Chemotherapy 52:6, pages 2263-2265.
Crossref
Crossref
Kain Regena Juliana & Chen Zhengxing. (2008) Effects of Processing Methods on the Physico-Functional Properties of
Peanut Flour (Arachis hypogaea L.). Biotechnology(Faisalabad) 7:2, pages 168-174.
Crossref
Crossref
Benjamin D. Brielmaier, Ed Casabar, Christine M. Kurtzeborn, Peggy S. McKinnon & David J. Ritchie. (2012) Early Clinical Experience with Anidulafungin at a Large Tertiary Care Medical Center. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:1, pages 64-73.
Crossref
Crossref
Seema Parveen, Ashish D. Gupta & Ramasare Prasad. (2007) Arabinogalactan protein from Arachis hypogaea: Role as carrier in drug-formulations. International Journal of Pharmaceutics 333:1-2, pages 79-86.
Crossref
Crossref
Matthew E. Falagas, Fotinie Ntziora, Gregoria I. Betsi & George Samonis. (2007) Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials. International Journal of Antimicrobial Agents 29:2, pages 136-143.
Crossref
Crossref
John E. Bennett. (2006) Echinocandins for Candidemia in Adults without Neutropenia. New England Journal of Medicine 355:11, pages 1154-1159.
Crossref
Crossref
Andreja Hasenoehrl, Tatjana Galić, Gabrijela Ergović, Nataša Maršić, Mihael Skerlev, Joachim Mittendorf, Ulrich Geschke, Axel Schmidt & Wolfgang Schoenfeld. (2006)
In Vitro Activity and In Vivo Efficacy of Icofungipen (PLD-118), a Novel Oral Antifungal Agent, against the Pathogenic Yeast
Candida albicans
. Antimicrobial Agents and Chemotherapy 50:9, pages 3011-3018.
Crossref
Crossref
M. A. Pfaller, L. Boyken, R. J. Hollis, S. A. Messer, S. Tendolkar & D. J. Diekema. (2006)
In Vitro Susceptibilities of
Candida
spp. to Caspofungin: Four Years of Global Surveillance
. Journal of Clinical Microbiology 44:3, pages 760-763.
Crossref
Crossref
G. H. Talbot, J. Bradley, J. E. Edwards, D. Gilbert, M. Scheld & J. G. Bartlett. (2006) Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clinical Infectious Diseases 42:5, pages 657-668.
Crossref
Crossref
Ekatherina Charvalos, Manolis N. Tzatzarakis, Françoise Van Bambeke, Paul M. Tulkens, Aristidis M. Tsatsakis, George N. Tzanakakis & Marie-Paule Mingeot-Leclercq. (2006) Water-soluble amphotericin B–polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects. Journal of Antimicrobial Chemotherapy 57:2, pages 236-244.
Crossref
Crossref
Kenji Tabata, Masataka Katashima, Akio Kawamura, Atsunori Kaibara & Yusuke Tanigawara. (2006) Population Pharmacokinetic Analysis of Micafungin in Japanese Patients with Fungal Infections. Drug Metabolism and Pharmacokinetics 21:4, pages 324-331.
Crossref
Crossref
Herbert L. Bonkovsky, Dean P. Jones, Douglas R. LaBrecque & Steven I. Shedlofsky. 2006. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
503
550
.
P. Svoboda & I. Kantorová. 2006. Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine
595
603
.
P. Svoboda & I. Kantorová. 2006. Intensive Care Medicine. Intensive Care Medicine
595
603
.
Patrick Vandeputte, Gérald Larcher, Thierry Bergès, Gilles Renier, Dominique Chabasse & Jean-Philippe Bouchara. (2005)
Mechanisms of Azole Resistance in a Clinical Isolate of
Candida tropicalis
. Antimicrobial Agents and Chemotherapy 49:11, pages 4608-4615.
Crossref
Crossref
Oksana Anatolia Shlobin, Lesia K. Dropulic, Jonathan B. Orens, John F. Mcdyer, John V. Conte, Stephen Y. Yang & Reda Girgis. (2005) Mediastinal Mass Due to Aspergillus fumigatus After Lung Transplantation: A Case Report. The Journal of Heart and Lung Transplantation 24:11, pages 1991-1994.
Crossref
Crossref
Donna M. MacCallum, Julie A. Whyte & Frank C. Odds. (2005) Efficacy of Caspofungin and Voriconazole Combinations in Experimental Aspergillosis. Antimicrobial Agents and Chemotherapy 49:9, pages 3697-3701.
Crossref
Crossref
Ruta Petraitiene, Vidmantas Petraitis, Amy M. Kelaher, Alia A. Sarafandi, Diana Mickiene, Andreas H. Groll, Tin Sein, John Bacher & Thomas J. Walsh. (2005)
Efficacy, Plasma Pharmacokinetics, and Safety of Icofungipen, an Inhibitor of
Candida
Isoleucyl-tRNA Synthetase, in Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits
. Antimicrobial Agents and Chemotherapy 49:5, pages 2084-2092.
Crossref
Crossref
Quanbo Xiong, Saad A. Hassan, William K. Wilson, Xiang Y. Han, Gregory S. May, Jeffrey J. Tarrand & Seiichi P. T. Matsuda. (2005)
Cholesterol Import by
Aspergillus fumigatus
and Its Influence on Antifungal Potency of Sterol Biosynthesis Inhibitors
. Antimicrobial Agents and Chemotherapy 49:2, pages 518-524.
Crossref
Crossref
Anant Mohan, Randeep Guleria, Chinmoyee Das, Surendra Kumar Sharma, Seema Mukhopadhyaya & Anupma Nayak. (2005) Invasive Tracheobronchial Aspergillosis in an Immunocompetent Person. The American Journal of the Medical Sciences 329:2, pages 107-109.
Crossref
Crossref
CURTIS D. HOLT & DREW J. WINSTON. 2005. Transplantation of the Liver. Transplantation of the Liver
963
994
.
Jill P. Adler-Moore, Jon A. Olson & Richard T. Proffitt. (2004) Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis. Journal of Antimicrobial Chemotherapy 54:6, pages 1096-1102.
Crossref
Crossref
Axel Glasmacher. (2004) Invasive Fungal Infections in Patients with Hematologic Malignancies: The Next Steps. Supportive Cancer Therapy 2:1, pages 31-33.
Crossref
Crossref
Angela Rösen-Wolff, Anne Koch, Wilhelm Friedrich, Gabriele Hahn, Manfred Gahr & Joachim Roesler. (2004) Successful Elimination of an Invasive Aspergillus nidulans Lung Infection by Voriconazole After Failure of a Combination of Caspofungin and Liposomal Amphotericin B in a Boy With Chronic Granulomatous Disease. The Pediatric Infectious Disease Journal 23:6, pages 584-586.
Crossref
Crossref
K. Hübel, J. Chemnitz, H.-G. Brochhagen & O. A. Cornelya. (2004) Successful Treatment of Chronic Disseminated Candidiasis with Caspofungin and Itraconazole in a Patient with Progressive Acute Leukemia and Prolonged Neutropenia. International Journal of Hematology 79:3, pages 289-292.
Crossref
Crossref
Punam Sandhu, Xin Xu, Peter J. Bondiskey, Suresh K. Balani, Michael L. Morris, Yui S. Tang, Alisha R. Miller & Paul G. Pearson. (2004) Disposition of Caspofungin, a Novel Antifungal Agent, in Mice, Rats, Rabbits, and Monkeys. Antimicrobial Agents and Chemotherapy 48:4, pages 1272-1280.
Crossref
Crossref
Arnab Pain, John Woodward, Michael A Quail, Michael J Anderson, Richard Clark, Matthew Collins, Nigel Fosker, Audrey Fraser, David Harris, Natasha Larke, Lee Murphy, Sean Humphray, Susan O’Neil, Mihaela Pertea, Claire Price, Ester Rabbinowitsch, Marie-Adele Rajandream, Steven Salzberg, David Saunders, Kathy Seeger, Sarah Sharp, Tim Warren, David W Denning, Bart Barrell & Neil Hall. (2004) Insight into the genome of Aspergillus fumigatus: analysis of a 922kb region encompassing the nitrate assimilation gene cluster. Fungal Genetics and Biology 41:4, pages 443-453.
Crossref
Crossref
Dorit Avrahami & Yechiel Shai. (2004) A New Group of Antifungal and Antibacterial Lipopeptides Derived from Non-membrane Active Peptides Conjugated to Palmitic Acid. Journal of Biological Chemistry 279:13, pages 12277-12285.
Crossref
Crossref
John R Wingard & Helen Leather. (2004) A new era of antifungal therapy. Biology of Blood and Marrow Transplantation 10:2, pages 73-90.
Crossref
Crossref